A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
Phase 3
Recruiting
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Biological: CLS2901C (human [allogeneic] chondrocyte sheets)
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06549686
- Locations
- 🇯🇵
Yokohama City University Medical Center, Yokohama, Kanagawa, Japan
🇯🇵Tokai University Hospital, Isehara, Kanagawa, Japan
🇯🇵Yokohama Sekishinkai Hospital, Yokohama, Kanagawa, Japan
A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
Phase 3
Terminated
- Conditions
- Superficial Esophageal Cancer
- Interventions
- Combination Product: CLS2702C/CLS2702D
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04689594
- Locations
- 🇯🇵
Okayama University Hospital, Okayama, Japan
Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer
Phase 3
Completed
- Conditions
- Superficial Esophageal Cancer
- Interventions
- Device: CLS2702C/CLS2702D
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02866019
- Locations
- 🇯🇵
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
🇯🇵National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath